Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in alylaly mice

Yoshinori Seo, Hidefumi Fukushima, Toshimasa Maruyama, Kayoko Nakao Kuroishi, Kenji Osawa, Kenichi Nagano, Kazuhiro Aoki, Falk Weih, Takahiro Doi, Min Zhang, Keiichi Ohya, Takenobu Katagiri, Ryuji Hosokawa, Eijiro Jimi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

We previously reported that alymphoplasia (alylaly) mice, which have a natural loss-of-function mutation in the Nik gene, which encodes a kinase essential for the processing of p100 to p52 in the alternative nuclear factor-κB (NF-κB) pathway, show mild osteopetrosis with an increase in several parameters of bone formation: bone formation rate, mineral apposition rate, and osteoblast number. We therefore investigated the molecular mechanisms triggered by the alternative NF-κB pathway in the regulation of osteoblast differentiation using primary osteoblasts (POB) prepared from alylaly mice. Alkaline phosphatase (ALP) activity and mineralization induced by the presence of β-glycerophosphate and ascorbic acid were enhanced in POB from alylaly compared with wild-type (WT) mice. Furthermore, osteoblastic differentiation induced by bone morphogenetic protein 2 (BMP2), as shown by ALP activity, mRNA expression of osteocalcin, Id1, Osterix and Runx2, and Sma- and Mad-related protein (Smad)1/5/8 phosphorylation, was also enhanced in POB from alylaly mice. The ectopic bone formation in vivo that was induced by BMP2 was enhanced in alylaly mice compared with controls. Transfection of a mutant form of p100, p100ΔGRR, which cannot be processed to p52, stimulated ALP activity and Smad phosphorylation. In contrast to p100ΔGRR, overexpression of p52 inhibited these events. Both BMP2-induced ALP activity and Smad phosphorylation were reduced in POB from p100-deficient mice, which carry a homozygous deletion of the COOH-terminal ankyrin repeats of p100 but still express functional p52 protein. p52 and p100ΔGRR interacted with a BMP receptor, ALK2, in overexpressed COS7 cells and changed the ALK2 protein levels in opposite directions: p52 reduced ALK2 and p100 increased it. Thus, the alternative the NF-κB pathway via the processing of p52 from p100 negatively regulates osteoblastic differentiation and bone formation by modifying BMP activity.

Original languageEnglish
Pages (from-to)414-422
Number of pages9
JournalMolecular Endocrinology
Volume26
Issue number3
DOIs
Publication statusPublished - Mar 1 2012
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Endocrinology

Fingerprint Dive into the research topics of 'Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in alylaly mice'. Together they form a unique fingerprint.

  • Cite this

    Seo, Y., Fukushima, H., Maruyama, T., Kuroishi, K. N., Osawa, K., Nagano, K., Aoki, K., Weih, F., Doi, T., Zhang, M., Ohya, K., Katagiri, T., Hosokawa, R., & Jimi, E. (2012). Accumulation of p100, a precursor of NF-κB2, enhances osteoblastic differentiation in vitro and bone formation in vivo in alylaly mice. Molecular Endocrinology, 26(3), 414-422. https://doi.org/10.1210/me.2011-1241